Download our whitepaper on advancing preclinical large molecule development with Tissue Cross-Reactivity.
Tissue Cross-Reactivity (TCR) assays are a vital screening tool and a regulatory necessity before clinical phases can begin. Although strategic considerations and regulatory recommendations for TCR assay parameters have changed over time, their impact on contemporary drug development is crucial.
Locked content
Sign up to download this file